'Promising': COVID-19 vaccine 'safe, well-tolerated' in younger children, Pfizer says
At just a third of the adult dose, Pfizer says data from its COVID-19 vaccine study for 5 to 11-year-olds shows the shot is "safe, well-tolerated and showed robust neutralizing ant…